Yesterday | The Morning Call
Eighty to lose jobs in Merck plant closure
Eighty people will lose their jobs starting in January when Merck & Co. closes a warehouse and shipping hub in Upper Macungie Township, the state announced today.
Will the M&A Wave Push Financial ETFs Higher?
Over the past few weeks, there has been a resurgence in acquisition activity, fueling an already strong market rally.
The marriage between Merck and Schering-Plough is already starting to produce offspring.
4-Star Stocks Poised to Pop: Merck
Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, drug behemoth Merck has earned a respected four-star ranking .
Merger-related cuts at Merck and Pfizer show how the mighty drug industry has fallen.
How Merck Lost $2.3B in the Bermuda Triangle
Merck must pay $2.3 billion in tax following a dispute with the IRS over cash the company parked in the Caribbean.
Cheap Niacin Beats Pricier Zetia in Heart Patients
Results reported here Sunday may not put the nail in the coffin for a once wildly popular cholesterol-lowering drug, but they do put Zetia at the bottom of the list of medications that doctors will be using.
Eduardo Pisani Of Bristol-Myers Squibb Is New IFPMA Director General
By Kaitlin Mara @ 4:00 pm The International Federation of Pharmaceutical Manufacturers and Associations has appointed a new director general, Eduardo Pisani, to take office 1 January 2010.
B&L seats pharmaceutical exec on board of directors
Bausch & Lomb Inc. has seated Fred Hassan on the company board of directors. B&L made the announcement Thursday.
Schering-Plough's $10M Experiment With Digital Out-of-Home
When Schering-Plough, the pharmaceutical/package-goods giant behind brands like Claritin, Dr.
Merck CEO Clark Eyes Retirement, and a $23M Golden Handshake
With the Schering-Plough merger done, Merck CEO Richard Clark is already mulling who will succeed him in the bosses' chair.
Why bigger makes our company better. Today, Merck and Schering-Plough completed our global merger.
Industrial Maintenance & Plant Operat...
Merck Eager For More Takeovers
The new Merck & Co. becomes the world's second-biggest drugmaker overnight, and it's boasting a fat wallet to fund future deals.
A Little Distracted, Are You, Merck?
What's the only thing more embarrassing for a drugmaker than getting a "complete response letter" for a New Drug Application from the Food and Drug Administration? Having the FDA refuse to file its NDA in the first place.
Merck, now No. 2 drugmaker, set for future buys
KXNet.com North Dakota News _title> _head> _script> _script> JavaScript DHTML Dro0 Down Men5 By Milonic _a> _div> Merck, now No.
Data Supporting Boceprevir Response Guided Therapy Presented at...
Schering-Plough Corporation today reported two data presentations supporting response guided therapy with boceprevir combination therapy in patients with chronic hepatitis C virus genotype 1. These retrospective analyses were presented at the American Association for the Study of Liver Diseases Annual Meeting in Boston, Oct.
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary ...
Schering-Plough Corporation announced that its investigational sublingual Grass Allergy Immunotherapy Tablet has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma.
Merck, Now No. 2 Drugmaker, Set for Future Buys
The new Merck & Co . has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing.
Technically, Schering lives on as a quirk; It was a reverse merger , after all. But after Schering bought Merck As "Merck," it answers the call.
1310States:NJ,NY,BA; US:DSF; Intl:; Fmts:Print, Online, Broadcast;...
Merck disclosed the rare move by the Food and Drug Administration in a regulatory filing Monday.
Also on Topix